UA43337C2 - Гормональний засіб для лікування вугрів - Google Patents

Гормональний засіб для лікування вугрів

Info

Publication number
UA43337C2
UA43337C2 UA95125308A UA95125308A UA43337C2 UA 43337 C2 UA43337 C2 UA 43337C2 UA 95125308 A UA95125308 A UA 95125308A UA 95125308 A UA95125308 A UA 95125308A UA 43337 C2 UA43337 C2 UA 43337C2
Authority
UA
Ukraine
Prior art keywords
hormonal
blackheads
treating
daily doses
hormonal means
Prior art date
Application number
UA95125308A
Other languages
English (en)
Russian (ru)
Inventor
Маріка Ерліх
Марика Ерлих
Герберт Куль
Original Assignee
Маріка Ерліх
Марика Ерлих
Герберт Куль
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6491735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA43337(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Маріка Ерліх, Марика Ерлих, Герберт Куль filed Critical Маріка Ерліх
Publication of UA43337C2 publication Critical patent/UA43337C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)

Abstract

Гормональний засіб для лікування вугрів включає два гормональні компоненти. При використанні цього засобу загальна кількість добових доз дорівнює загальній кількості діб у бажаному циклі. Перший гормональний компонент взято у кількості від 5 до 14, а другий - від 23 до 14 добових доз. Кількість добових доз першого гормонального компоненту менша кількості добових доз другого гормонального компоненту.
UA95125308A 1993-07-01 1994-06-03 Гормональний засіб для лікування вугрів UA43337C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4321957A DE4321957C2 (de) 1993-07-01 1993-07-01 Verwendung eines hormonalen Mittels zur Therapie der Akne
PCT/DE1994/000629 WO1995001180A1 (de) 1993-07-01 1994-06-03 Hormonales mittel zur therapie der akne und dessen verwendung

Publications (1)

Publication Number Publication Date
UA43337C2 true UA43337C2 (uk) 2001-12-17

Family

ID=6491735

Family Applications (1)

Application Number Title Priority Date Filing Date
UA95125308A UA43337C2 (uk) 1993-07-01 1994-06-03 Гормональний засіб для лікування вугрів

Country Status (14)

Country Link
EP (1) EP0710111B1 (uk)
JP (1) JPH09500112A (uk)
AT (1) ATE205716T1 (uk)
AU (1) AU695894B2 (uk)
BR (1) BR9407340A (uk)
CA (1) CA2166121A1 (uk)
DE (2) DE4321957C2 (uk)
DK (1) DK0710111T3 (uk)
ES (1) ES2164103T3 (uk)
HU (1) HUT73234A (uk)
NO (1) NO308586B1 (uk)
PT (1) PT710111E (uk)
UA (1) UA43337C2 (uk)
WO (1) WO1995001180A1 (uk)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19534209A1 (de) * 1995-09-15 1997-03-20 Jenapharm Gmbh Hormonales Mittel zur Behandlung der Haut
AU1690399A (en) * 1997-12-26 1999-07-19 Mochida Pharmaceutical Co., Ltd. Neovascularization inhibitor containing dienogest as the active ingredient
DE102004026671A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
DE102004026679A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026670A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102006003509A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Kontrazeptivum
DE102006003508A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Arzneimittel umfassend eine Hormonkombination

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU565915B2 (en) * 1982-12-31 1987-10-01 Mortimer, C.H. Pharmaceutical composition of antibiotic and anti- androgen
DE3442857A1 (de) * 1984-11-22 1986-05-22 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur behandlung von androgenisierungserscheinungen bei der frau
DE3916112A1 (de) * 1989-05-16 1990-11-22 Schering Ag Dihydrospirorenon als antiandrogen
DE4104385C1 (uk) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
AU695894B2 (en) 1998-08-27
NO955347D0 (no) 1995-12-29
DE4321957A1 (de) 1995-01-12
BR9407340A (pt) 1996-10-08
HUT73234A (en) 1996-07-29
DE4321957C2 (de) 1995-09-28
DK0710111T3 (da) 2001-12-10
DE59409869D1 (de) 2001-10-25
ES2164103T3 (es) 2002-02-16
EP0710111A1 (de) 1996-05-08
WO1995001180A1 (de) 1995-01-12
HU9503770D0 (en) 1996-02-28
ATE205716T1 (de) 2001-10-15
PT710111E (pt) 2002-02-28
CA2166121A1 (en) 1995-01-12
JPH09500112A (ja) 1997-01-07
NO308586B1 (no) 2000-10-02
AU6840894A (en) 1995-01-24
EP0710111B1 (de) 2001-09-19
NO955347L (no) 1995-12-29

Similar Documents

Publication Publication Date Title
MY106272A (en) Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants.
WO1994027589A3 (en) Antidepressant dosage form
ES2011120A6 (es) Forma de dosificacion para tratar las enfermedades cardiovasculares.
CZ540990A3 (en) Microbicidal agent
MX9803604A (es) Composiciones topicas para regular la apariencia grasosa/brillosa de la piel.
IL76932A0 (en) Pharmaceutical compositions containing dihydrocodeine and ibuprofen
PL315119A1 (en) Agent for and method of performing hormonal contraception and/or treating acne
HU9503605D0 (en) Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
EP0489647A3 (en) N,o-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them
MX9804395A (es) Proceso y equipo anticonceptivos para mamiferos hembra, que comprenden una combinacion de gestageno y estrogeno.
GEP20012512B (en) Inhibition of 26S and 20S Proteasome by Indanones
MY106528A (en) Method of treating impotence.
AU4176985A (en) Kit for use in the treatment of osteoporosis
MX9602442A (es) Un tratamiento con fluoroquinolona a dosis unica elevada.
MX9702035A (es) Inhibidores de 5-alfa reductasa.
UA43337C2 (uk) Гормональний засіб для лікування вугрів
KR100213963B1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
EP0366753A4 (en) N-ALKOXYALKYLAMID AND COSMETIC TREATMENT COMPOSITIONS.
CA2179778A1 (en) Deuterised active agents in transdermal application
CA2137595A1 (en) Treating hormone-dependent conditions
SG46620A1 (en) Method and composition foor the treatment of autoimmune hepatitis
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
GR3036827T3 (en) Method and composition for the treatment of hair loss.